# Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept

> **NCT04947137** · PHASE2 · COMPLETED · sponsor: **Navidea Biopharmaceuticals** · enrollment: 134 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Tc99m tilmanocept

## Key facts

- **NCT ID:** NCT04947137
- **Lead sponsor:** Navidea Biopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-27
- **Primary completion:** 2022-01-21
- **Final completion:** 2022-01-21
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2025-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04947137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04947137, "Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04947137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*